Stay informed with the latest updates for the inheritable blood disorders community. Industry Aptevo Announces Patient-Reported Study Results Related to IXINITY® UseMar 20, 2018 Industry Novo Nordisk Announces BLA Submission for Extended Half-Life FVIII Therapy…Mar 6, 2018 Industry REBINYN® Now Available for Hemophilia B PatientsFeb 9, 2018 Industry Catalyst Begins Phase 2/3 Trial of Investigational Subcutaneous TherapyJan 8, 2018 Industry BioMarin Reports Positive Gene Therapy Trial Data at ASHDec 19, 2017 Industry Alnylam Announces FDA Lift of Hold on Fitusiran TrialsDec 18, 2017 Industry Shire and Rani Agree to Collaborate on Development of…Dec 14, 2017 Industry Spark Reports Positive Clinical Trial Data on Hemophilia A and…Dec 13, 2017 Industry HEMLIBRA® Shows Prophylactic Efficacy in Hemophilia A Patients…Dec 5, 2017 Industry First Patient Enrolled in ITI Trial Using Eloctate Nov 21, 2017 Industry FDA Grants Orphan Drug Designation for Rofecoxib, Pain…Nov 21, 2017 Industry Alnylam Announces Successful Meeting with FDA on Fitusiran Nov 13, 2017 Industry Study Shows Positive Joint Outcomes in…Nov 6, 2017 Industry FDA Accepts Application for Bayer’s Investigational Hemophilia A TherapyNov 6, 2017 Industry FDA Grants Breakthrough Therapy Designation for…Oct 30, 2017 Pagination First page Previous page … Page 6 Page 7 Page 8 Page 9 Current page 10 Page 11 Page 12 Page 13 Page 14 … Next page Last page